Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71926 - 71950 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	NR3C2	4306	upregulated	Silicon Dioxide results in increased expression of NR3C2 mRNA	4q31	A24196
Silicon dioxide	Approved	NR4A1	3164	upregulated	Silicon Dioxide analog results in increased expression of NR4A1 mRNA	12q13.13	A24194
Silicon dioxide	Approved	NR4A2	4929	downregulated	Silicon Dioxide analog results in decreased expression of NR4A2 mRNA	2q22-q23	A24195
Silicon dioxide	Approved	NR4A2	4929	upregulated	Silicon Dioxide analog results in increased expression of NR4A2 mRNA	2q22-q23	A24194
Silicon dioxide	Approved	NR4A3	8013	downregulated	Silicon Dioxide analog results in decreased expression of NR4A3 mRNA	9q22	A24195
Silicon dioxide	Approved	NR4A3	8013	upregulated	Silicon Dioxide analog results in increased expression of NR4A3 mRNA	9q22	A24194
Silicon dioxide	Approved	NR4A3	8013	upregulated	Silicon Dioxide results in increased expression of NR4A3 mRNA	9q22	A24197 A24196
Silicon dioxide	Approved	NRCAM	4897	upregulated	Silicon Dioxide results in increased expression of NRCAM mRNA	7q31.1	A24196
Silicon dioxide	Approved	NRDE2	55051	upregulated	Silicon Dioxide results in increased expression of NRDE2 mRNA	14q32.11	A24196
Silicon dioxide	Approved	NREP	9315	downregulated	Silicon Dioxide analog results in decreased expression of NREP mRNA	5q22.1	A24195
Silicon dioxide	Approved	NREP	9315	downregulated	Silicon Dioxide results in decreased expression of NREP mRNA	5q22.1	A24197 A24196
Silicon dioxide	Approved	NRG1	3084	upregulated	Silicon Dioxide analog results in increased expression of NRG1 mRNA	8p12	A24195
Silicon dioxide	Approved	NRG1	3084	upregulated	Silicon Dioxide results in increased expression of NRG1 mRNA	8p12	A24196
Silicon dioxide	Approved	NRG4	145957	downregulated	Silicon Dioxide analog results in decreased expression of NRG4 mRNA	15q24.2	A24195
Silicon dioxide	Approved	NRGN	4900	downregulated	Silicon Dioxide analog results in decreased expression of NRGN mRNA	11q24.2	A24195
Silicon dioxide	Approved	NRIP2	83714	downregulated	Silicon Dioxide analog results in decreased expression of NRIP2 mRNA	12p13.33	A24194
Silicon dioxide	Approved	NRIP2	83714	upregulated	Silicon Dioxide analog results in increased expression of NRIP2 mRNA	12p13.33	A24195
Silicon dioxide	Approved	NRIP3	56675	upregulated	Silicon Dioxide analog results in increased expression of NRIP3 mRNA	11p15.4	A24195
Silicon dioxide	Approved	NRIP3	56675	upregulated	Silicon Dioxide results in increased expression of NRIP3 mRNA	11p15.4	A24196
Silicon dioxide	Approved	NRP2	8828	downregulated	Silicon Dioxide results in decreased expression of NRP2 mRNA	2q33.3	A24196
Silicon dioxide	Approved	NRTN	4902	downregulated	Silicon Dioxide analog results in decreased expression of NRTN mRNA	19p13.3	A24195
Silicon dioxide	Approved	NRXN3	9369	downregulated	Silicon Dioxide analog results in decreased expression of NRXN3 mRNA	14q31	A24194
Silicon dioxide	Approved	NSD2	7468	downregulated	Silicon Dioxide analog results in decreased expression of NSD2 mRNA	4p16.3	A24195
Silicon dioxide	Approved	NSD2	7468	upregulated	Silicon Dioxide analog results in increased expression of NSD2 mRNA	4p16.3	A24194
Silicon dioxide	Approved	NSFL1C	55968	upregulated	Silicon Dioxide results in increased expression of NSFL1C mRNA	20p13	A24196

Displaying entries 71926 - 71950 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability